Events And

American Association for the Study of Liver Disease, The Liver Meeting®, Washington, DC

Nov 07, 2022 at 1:00 PM EST

Poster Presentation: Effects of a Balanced GLP-1/Glucagon Receptor Dual Agonist on Reduction of Liver Fat and Weight Loss: Results of a Phase 1b Multicenter, Randomized, Double-blind, Placebo-controlled Trial in Patients with Non-alcoholic Fatty Liver Disease

Lead Author: Stephen A. Harrison, MD, Medical Director, Pinnacle Research

Supporting Materials


Investor Contact

Richard Eisenstadt
Chief Financial Officer



Email Alerts

Automatically receive Altimmune, Inc. financial information by e-mail